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a  b  s  t  r  a  c  t
Operculina  macrocarpa  (L.)  Urb.,  Convolvulaceae,  is  used  by the  population  as  a laxative.  In  this  work
we  described  the isolation  of  the  three  phenolic  acids  present  in  the  hydroethanolic  extract  of  the
O.  macrocarpa  roots.  The  quantiﬁcation  of  the  caffeic,  chlorogenic  acids  and  of the  new  caffeic  dimer
in  the  hydroethanolic  and  infusion  extracts  was performed  by high-performance  liquid  chromatography
coupled  photodiode  array  detector.  These  analyses  showed  the  higher  content  of the  chlorogenic,  caffeic
and the  new  3,4′-dehydrodicaffeic  acid in hydroethanolic  and  hydroethanolic  extracts  without  resin  in
which  infusion.  The  acid found  in  greater  quantity  is caffeic  acid followed  by  the  3,4′-dehydrodicaffeic
acid. The  laxative  activity  was  evaluated  by different  experimental  models  of intestinal  transit  with  theaxative
perculina macrocarpa
henolic acids
hydroethanolic  and  infusion  extracts,  and  the  resin  fraction,  caffeic,  chlorogenic  and  ferulic  acids.  The
results  showed  all extracts  and  compounds  tested  had  signiﬁcant  activity  in the  experimental  model
tested.  These  results  obtained  are  essential  for  the future  development  of  a  pharmaceutical  product  with
safety and  efﬁcacy.
©  2016  Sociedade  Brasileira  de Farmacognosia.  Published  by Elsevier  Editora  Ltda.  This  is  an open
he  CCaccess  article  under  t
ntroduction
The therapy based on plants dates back to the origins of human-
ty and, has always had an important role in the community health
ver time. According to the World Health Organization (WHO),
edicinal plants are the best sources to obtain drugs (WHO, 2002).
Medicinal plants have an important role in the Brazilian culture
nd tradition. Nowadays, the majority of the urban population, as
ell as the rural communities, use phytomedicines as medicinal
reatments although a few number of species were studied by
he chemical and pharmacological point of view. In this sense, the
valuation of the therapeutic potential and chemical composition
f these plants can contribute to the development of the Brazilian
hytotherapy. The security and efﬁciency in the use of phytother-
pics should be based on the existence of relevant scientiﬁc
iterature grounded on the demonstration of its pharmacological
ctivity, clinical efﬁcacy and its toxicity. As for security, the knowl-
dge that guarantees the use of many phytotherapics comes from
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traditional medicine and the ethnomedicinal knowledge gathered
for centuries (Carvalho, 2005).
Operculina macrocarpa (L.) Urb., Convolvulaceae, popularly
known as “batata-de-purga” or “jalapa”, (syn. Ipomoea purga
Hayne) (Xavier et al., 1994) from the northeast of Brazil, and widely
used by population due to its laxative, purgative and depura-
tive activity against skin diseases and in the leucorrhea treatment
(Matos, 1982; Martins et al., 2000).
According to Kohli et al. (2010) in Ayurveda, O. turpethum has
been included in the group of ‘ten purgative herbs’. The presence
of resin glycosides in Convolvulaceae family has been established
associated with the laxative properties of the herbal drugs. Resin
glycosides were classiﬁed into two  groups: jalapin and convolvulin.
The jalapin group presents the common structure of a macro-
lactone with one acylated glycosidic acid while the convolvulin
groups are oligomers of glycosidic acids (Pereda-Miranda et al.,
2006). Previously we  have reported the intestinal motility from
the dichloromethane, ethyl acetate and residual fractions, and the
powder preparation of O. macrocarpa (Michelin and Salgado, 2004).
Xavier et al. (1994) isolated from the leaves of this species two
C-ﬂavonoids. Despite the popular use of this specie it is funda-
mental a meticulous study about the chemical composition and its
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axative effect. The present study is therefore, aimed to the isolation
he phenolic compounds presents in the hydroethanolic extract of
oots of the O. macrocarpa and the evaluation of the laxative effect of
he extracts, resin fraction and the compounds isolated of this plant.
aterial and methods
lant material
Operculina macrocarpa (L.) Urb., Convolvulaceae, was collected
n the garden of Medicinal Plants Uniararas, and the exsiccate was
dentiﬁed and included in the collection of the ESA-Agriculture
chool Luiz de Queiroz Herbarium, Department of Biological Sci-
nces ESALQ/USP, registration number ESA114652.
The roots were previously shaved and dried in an air heater, at
 temperature of 45 ◦C until it was reached a constant weight, and
hen they were crushed in a ball grinder to reduce the size of the
articles.
hemicals
Caffeic acid, chlorogenic acid and ferulic acid, both solid state,
ere purchased from Sigma (St. Louis, MO,  USA). Analytical grade
cetic acid was purchased from Riedel-de Haën (Seelze, Germany).
ethanol (HPLC grade) was purchased from Merck (Darmstadt,
ermany). HPLC-grade water (18 M cm)  was obtained using a
irect Q5 Milli-Q puriﬁcation system (Millipore Co., Bedford, MA,
SA).
xtraction
The powder of the roots (200 g) of O. macrocarpa was previ-
usly moistened with ethanol 70◦GL and maintained during 2 h.
hen, this mixture was transferred in to the percolator and com-
leted with 2 l of the solvent. The reduction of the solvent volume
as obtained by the utilization of a rotatory evaporator. During
his process was observed the precipitation of a yellowish brown
olid, the resin fraction (5 g; 2.5% of yield). This material was  sep-
rated by decantation. After all the process were obtained 36 g of
ry hydroethanolic extract (EEtOH; 18% of yield).
reparation of the infusion
The dry and pulverized roots (200 g) were heated and boiled for
0 min  in 2 l of water to extract effective components, and removed.
fter ﬁltration, the infusion extract was concentrated in a rotary
vaporator and it was frozen and lyophilized, furnishing 46.2 g of
he infusion extract (23% of yield).
hromatographic methods
xtract chromatographic proﬁle by HPLC-UV-PDA
The analysis of the chemical proﬁle of the O. macrocarpa
xtracts were performed in a High Performance Liquid Chromato-
raph with a Photodiode Array Detector (HPLC-UV-PDA), brand
arianTM model ProStar 210/330. The separation was performed
n a reverse phase Luna C18 column (250 mm × 4.6 mm,  5 m)
PhenomenexTM), equipped with a Phenomenex Security Guard
4 mm × 3 mm,  5 m).  Samples and patterns were injected through
 RheodyneTM 7125 injector with a 20 l loop.
Approximately 20 mg  of each EEtOH and infusion were dis-
olved in 1 ml  of methanol/water (1:1, v/v). For the removal of
ossible lipophilic compounds, each solution was puriﬁed by solid
hase extraction (SPE), using Phenomenex Strata C18 cartridges
500 mg  of stationary phase), previously activated with 5 ml  of
ethanol and equilibrated with 5 ml  of HPLC-grade water. The Farmacognosia 26 (2016) 427–432
samples were eluted from cartridges using 5 ml  of a mixture of
methanol/water (1:1, v/v). The samples were then ﬁltered through
a 0.45 m polytetraﬂuoroethylene (PTFE) ﬁlter and aliquots of 20 l
were directly injected into HPLC.
The mobile phase compositions used were water (eluent A)
and acetonitrile (eluent B), both containing 0.05% triﬂuoroacetic
acid. The gradient programme was  as follows: 28–40% B (20 min),
40–70% B (1 min), 70–100% B (10 min) and 100% (9 min). Total run
time was 40 min. The ﬂow-rate of the mobile phase was 1.0 ml/min.
Star LC Workstation software was used both for the operation of the
detector and for data processing.
Isolation of phenolic acids
The EEtOH extract (4 g) was fractionated by gel permeation
column chromatography. The column was packed with Sephadex
LH-20 (57 cm × 3.0 cm i.d.) and soaked with methanol. The column
was then eluted with the same solvent mixture yielded 156 frac-
tions (5 ml  each one). After TLC analysis, similar fractions were
combined to yield 28 subfractions.
Part of subfraction 17 (25 mg)  was  refrationated on a sil-
ica gel column using the mixture of chloroform/methanol/water
(43:37:20, v/v, organic phase) as mobile phase. This procedure
furnished a white precipitated (13 mg,  caffeic and protocatechuic
acids). The other compound was  obtained from the subfraction 25
(50 mg) by column chromatography (CC) using as mobile phase the
mixture of ethyl acetate/acetic acid/water (15:0.5:0.1, v/v). This
procedure furnished a white precipitated (14 mg,  the new com-
pound 3,4′-dehydrodicaffeic acid).
Quantitative analysis of phenolic acids
The quantitative analysis of phenolic compounds in the
O. macrocarpa extract and infusion was performed by HPLC-UV-
PDA using the conditions describe in Extract chromatographic proﬁle
by HPLC-UV-PDA section.
These experiments permitted the determination of the chloro-
genic and caffeic acids, and caffeic dimer. The identiﬁcation was
performed by comparison retention time, by spiking with known
standards, and by comparison with previously isolated compounds
under the same conditions. Methods using external standards were
used to quantify each compound.
These curves were obtained from seven stock solutions
(1000 g/ml) in the range of concentrations between 1 and
100 g/ml. The dilutions were made in water/methanol (1:1, v/v),
and were injected in the HPLC-UV-PDA. All experiments were made
in triplicate. The analytical curves had good linearity in the concen-
tration range studied and presented correlation coefﬁcients (r) with
values above 0.999, which suggests as a good correlation between
the areas and the concentrations studied.
NMR analysis
The 1H NMR  and 13C NMR  1D and 1H NMR 2D-NMR 13C g-
HMBC experiments were obtained using a Bruker® spectrometer
at 300 MHz  frequency (7.0 T) and on a Varian Inova® spectrome-
ter at 500 MHz  frequency (11.7 T). The samples were dissolved in
dimethyl sulfoxide (DMSO-d6) containing TMS for chemical refer-
ence.
Direct-injection ESI/MS and ESI/MS/MS analysis
The ESI analysis was  carried out on a LCQ FLEET Thermo
Scientiﬁc® equipped with an ion trap analyzer system: data were
acquired using Xcalibur 2.1.0.2.40 software. The source tempera-
ture was  set at 250 ◦C, and the source voltage was  constant at 3.5 kV.
Nitrogen was used as sheath and nebulizer gas at 5 l/min and 10 psi.
Helium was  introduced into the system at an estimated pressure
of 6 × 10−6 mbar to improve trapping efﬁciency, and was provided
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he fragmentation amplitude varied between 0.6 and 0.9 V; the MS
perated in the negative ion mode with a scan rate of 13,000 u/s.
amples were infused into the ESI source by use of a syringe pump
t a ﬂow-rate of 5 l/min.
nimals
There were used Swiss mice (Mus  musculus),  male, 30 days of
ge, between 20 and 30 g of weight, adapted to the experimental
nimal facility for 5 days before the begin of the biological trials. The
nimals had free access to food and water, and were kept in room
emperature of 20 ± 1 ◦C, controlled humidity and a photoperiod of
2 h light/darkness. The day of the trial the animals were in fasting
or 3 h, receiving water ad libitum.
The animals used are from the Bioterism Centre of the São
aulo State University, Botucatu. The procedures were previously
pproved by the Ethics Research Committee of the São Paulo State
niversity, Araraquara, approval number 25/2006.
reparation of solid dispersion from the resin
Considering the insolubility of the resin in water, a solid dis-
ersion was prepared for oral administration in mice in the test of
ntestinal motility.
The solid dispersion was prepared dissolving the resin in an
thanolic solution of polivinilpirrolidone (10%). The ethanol was
vaporated in rotary evaporator at 50 ◦C. The ﬁnal concentration of
he solid dispersion was 12.5 mg/ml  of resin.
ntestinal transit with active charcoal
The animals were randomly separated in groups of ten animals
ach, and received the treatment by oral gavage administration.
 control group received saline solution. After 45 min, the animals
eceived a suspension of active charcoal 10% in a solution of 5% ara-
ic gum and 0.5 ml/animal, by gavage administration. After 45 min,
he mice were sacriﬁced in a CO2 chamber, and it was performed
n immediate extirpation of the intestine from the pylorus to the
eginning of the caecum. Thereby, it was made the measurement of
he total length of the small intestine and the distance travelled by
he active charcoal suspension. The results were expressed in per-
entage of the total length of small intestine. The intestines were
eighted individually in an analytical balance.
The activity in the intestinal transit was determined according
o Janssen and Jageneau (1957) and Wong and Way  (1981).
ntestinal transit with modiﬁed active charcoal (Marona and
ucchesi, 2004)
The animals were randomly separated in groups of ten each one,
nd received the oral treatment by gavage administration. A control
roup received saline solution. After 90 min, the animals received
 suspension of active charcoal 10% in an arabic gum solution 5%
nd 0.3 ml/animal, by gavage administration as well. After 60 min,
he animals had access again to food and water.
The mice were observed for 4 h each 5 min, and it was  timed
ow long did it take them to eliminate of the ﬁrst faeces with active
harcoal.
ntestinal transit in metabolic cageThe animals were randomly separated in groups of ten and
eceived the oral treatment by gavage administration. A con-
rol group received saline solution. The animals were placed in a Farmacognosia 26 (2016) 427–432 429
metabolic cage, and after 4 h the faeces were weighted and com-
pared to the control group.
Statistical analysis
The experimental results were expressed in mean ± standard
deviation. The statistical analysis was calculated by Student t-test
(p < 0.05) (De Muth, 1999).
Results and discussion
The phytochemical study of the EEtOH extract from the O.
macrocarpa resulted in the isolation of protocatechuic acid (1), caf-
feic acid (2) and the new compound 3,4′-dehydrodicaffeic acid (3).
The 1H NMR  analysis of the white crystal revealed the presence
of a mixture of two  compounds. The major compound was  identi-
ﬁed by the presence of the two  doublets at 7.02 ppm (J = 2.5 Hz, 1H)
and at 6.76 ppm (J = 8.5 Hz, 1H) and a double doublet at 6.95 ppm,
(J = 8.5 and 2.5 Hz, 1H), This coupling pattern of three aromatic
hydrogens suggested the existence of 1,3,4-trisubstituted benzene.
The two  large doublet at 6.17 ppm (J = 16.0 Hz, 1H) and at 7.38 ppm
(J = 16.0 Hz, 1H) indicated trans oleﬁnic hydrogens. These data char-
acterized the presence of the caffeic acid (2). The 13C NMR  data
corroborate this compound as the caffeic acid (Dürüst et al., 2001).
The same aromatic substitution pattern was observed for the
minor compound 1. The signals at 7.34 ppm (d, J = 2.5 Hz, 1H),
7.29 ppm (dd,  J = 8.5 and 2.5 Hz, 1H) and 6.78 ppm (d, J = 8.5 Hz, 1H).
The 13C NMR  spectrum revealed the presence of 7 signals being one
of them corresponding to a carbonyl carbon at 168.7 ppm. The spec-
tra analyze of the two-dimensional HMQC and HMBC experiments
allow the identiﬁcation of the minority compound as protocatech-









Analyzing the 1H NMR  spectra of another phenolic acid, showed
the presence of hydrogen signals with chemical shifts fairly con-
stant and similar couplings to those of the caffeic acid. However,
they are duplicated. Through the integration of the signals along
with analysis of 13C NMR  spectra and two-dimensional HMBC and
HMQC experiments it was possible to identify the new substance
as the caffeic dimer bound by positions 3 of the unity I with 4′ of
the unit II. The signals at 7.04 ppm (d, J = 2.5 Hz, 1H), 6.76 ppm (d,
J = 8.5 Hz, 1H) and 6.90 ppm (m,  1H) refers to hydrogens H-2, H-5
and H-6, respectively the aromatic ring of unit I. These assignments
can be made by the correlations observed in the HMBC spectrum.
The hydrogens of the trans double bond of that unit I can be assigned
by the signals at 6.24 ppm (d, J = 16.0 Hz, 1H) and 7.48 ppm (d,
J = 16.0 Hz, 1H), consecutively. The conﬁrmation that these signals
belonging to Unit I were given by correlations between the signal at
7.48 ppm and 6.24 ppm (H- and H-)  with a signal of a carbonyl
at 166.1 ppm, as well as the correlation between proton  of the
double bond (7.48 ppm) with C-6 at 121.0 ppm. These correlations
allowed the unambiguous assignment of the unit I. The aromatic
part of the unit II may be ascertained through signals at 7 ppm (d,
J = 2.5 Hz, 1-H), 6.78 ppm (d, J = 8.5 Hz, 1-H) and 6.90 ppm (m-  1H),
which refer to hydrogens H-2, H-5 and H-6, respectively. The sig-
nals at 7.45 ppm (d, J = 16.0 Hz, 1-H) and at 6.18 ppm (d, J = 16.0 Hz,
1-H) correlated with the signal at 165.6 ppm conﬁrm their
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Table 1
Percentage of distance travelled by the active charcoal in the intestine of mice treated with Operculina macrocarpa.
Treatment Dose (mg/kg) Distance travelled by the active charcoal (%) Weight of the intestin (g)
Control (saline) 10 ml/kg 72.01 ± 8.15 2.3983 ± 0.25
Infusion extract 1000 83.74 ± 12.20* 2.2830 ± 0.28
Infusion extract 500 75.34 ± 7.43 2.3139 ± 0.31































PResin  fraction 400 60.6
* p < 0.05; n = 10.
orrelation to the double bond of the unit II of the caffeic dimer. Sim-
larly to the unit I, it was possible to assign all signals through the
nalysis of the 1H and 13C NMR  spectra as well as two-dimensional
xperiments (HMBC and HMQC). To establish the linkage position
f the two caffeic unities was measured and a long range carbon
ydrogen correlation for H-2 (unity I) → C-4 (unity II) observed. In
rder to corroborate this structure we realized the ESI-MS experi-
ent. This experiment revealed the presence of a pseudomolecular
on m/z 341 [M−H]−. While in the MS2 showed abundant ions at
/z 179 (100) and 135 (90) which accords with the caffeic acid. In
omparison our data with those reported by Shaheen et al. (2011)
or the 3,3′-didehydrodicaffeic acid we conﬁrmed the presence of
he 3,4′-dehydrodicaffeic acid (3) (Plazonic´ et al., 2009).
13C NMR  (DMSO-d6, 125 MHz) for the 3,4′-dehydrodicaffeic acid
as: ı for unity I: 114.7 (C-), 114.8 (C-2), 115.8 (C-5), 121.0 (C-6),
25.5 (C-1), 145.5 (C-3), 144.6 (C-), 148.2 (C-4), 166.1 (COOH). For
he unity II: 114.2 (C-), 114.6 (C-2), 115.7 (C-5), 121.3 (C-6), 125.6























valuation of the laxative activity
Since the population uses O. macrocarpa as a laxative, this activ-
ty was evaluated using three experimental models.
The ﬁrst model evaluated was the one that uses active charcoal
s marker in order to observe the intestinal transit. The activ-
ty is determined by the distance travelled by the marker in the
mall intestine, compared to the control group. This method is
idely used to evaluate the activity of vegetal extracts (Michelin
nd Salgado, 2004; Figueiredo et al., 2005; Salgado et al., 2006).
The second model, proposed by Marona and Lucchesi (2004),
ses the same methodology as the ﬁrst one; however, in this model
he animals are not sacriﬁced, and can be used later on in another
xperiment, fact that helps with the wellbeing of the animal.
In the third model, animals are placed in a metabolic cage and
he activity is determined analyzing the faeces, differently of the
able 2
ercentage of the distance travelled by the active charcoal in the small intestine of mice t
Treatment Dose (mg/kg) Distance travell
Control (saline) 10 ml/kg 81.53 ± 9.75 
Caffeic acid 10 79.70 ± 13.05 
Caffeic acid 20 86.80 ± 10.99a
Ferulic acid 10 86.43 ± 16.63a
Ferulic acid 20 91.65 ± 13.60a
Chlorogenic acid 10 78.62 ± 9.34 
Chlorogenic acid 20 86.08 ± 7.16a
a p < 0.05; n = 10..79 2.5684 ± 0.28
other two models. In this model, the animals can also be used again
in other experiments since there is no need to sacriﬁce them.
According to literature, until now it is the ﬁrst study evaluating
the activity of O. macrocarpa in the intestinal transit, except by the
preliminary study, previous to this one, carried out by our research
group (Michelin and Salgado, 2004).
Intestinal transit with active charcoal
This test was  carried out in 1957 by Janssen and Jageneau, and it
was evaluated the inhibition of the gastrointestinal propulsion with
a charcoal suspension in mice. Then, Wong and Way  (1981) eval-
uated the effect of aspirin and acetaminophen in the inhibition of
the gastrointestinal propulsion induced by morphine in mice. The
trial was performed according to the second experimental model
developed by Janssen and Jageneau (1957) and Wong and Way
(1981).
The infusion extract and the standards of the caffeic, chlorogenic
and ferulic acid were evaluated using this experimental model.
The results shown in Table 1, demonstrate the signiﬁcant
increase of the intestinal motility, when compared to the control
group, caused by the infusion extract using a dosage of 1000 mg/kg.
Using a dosage of 500 mg/kg the result appeared to be not signiﬁ-
cant.
The EEtOH extract was  previously tested using a dosage of
1000 mg/kg, and the results showed a signiﬁcant increase of the
intestinal motility of mice (69.99%) when compared to the control
group (47.87%) (Michelin and Salgado, 2004). The low solubility
presented by the resin in water implied the preparation of a solid
dispersion to test in mice, however it did not show signiﬁcant activ-
ity in the concentration used.
The evaluation of the EEtOH extract after the precipitation of the
resin at the dose of 1000 mg/kg has showed a signiﬁcant increase
of the intestinal motility. Despite the higher quantity of 1–3 com-
pounds, were submitted to the same test. The three acids showed
a signiﬁcant increase of the intestinal motility in mice when com-
pared to the control group (Table 2).
The acids were tested in dosages of 10 and 20 mg/kg. The caffeic
acid presented activity in the dosage of 20 mg/kg, and travelled a
distance of 86.80% of the small intestine, while in the control group
it travelled a distance of 81.53%. The ferulic acid showed signiﬁ-
cant activity in the tested dosages, travelling 86.43 and 91.45% of
the small intestines using the dosages of 10 and 20 mg/kg, respec-
tively. Finally, the results obtained for the chlorogenic acid, were
reated with caffeic, ferulic and chlorogenic acids.
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Table  3
Elimination time of the faeces with marker in mice treated with Operculina
macrocarpa.
Treatment Dose (mg/kg) Time to eliminate the faeces
with marker (min)
Control (saline) 10 ml/kg 194.6 ± 30.37
EEtOH extract 1000 156.4 ± 23.29a
Infusion extract 1000 65.1 ± 4.70a
a p < 0.05; n = 10.
Table 4
Weight of the faeces eliminated by mice treated with Operculina macrocarpa.
Treatment Dose (mg/kg) Weight of the faeces (g)
Control (saline) 10 ml/kg 1.80 ± 0.23
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Fig. 1. HPLC separation chromatogram, in analytic mode (210 nm)  of the EEtOH
extract of Operculina macrocarpa. 1. clorogenic acid; 2. caffeic acid; 3. 3,4′-










































QInfusion extract 1000 3.98 ± 0.71
a p < 0.05; n = 10.
igniﬁcant in the dose of 20 mg/kg, having travelled a distance of
6.08%.
Based on these results, it can be suggested that phenolic acids
ave stimulant activity of the intestinal motility, since they are
resent in the EEtOH and infusion extracts of O. macrocarpa, where
his activity was also found.
ntestinal transit with modiﬁed active charcoal (Marona and
ucchesi, 2004)
In this model were evaluated the EEtOH and the infusion
xtracts of O. macrocarpa. This model of intestinal transit also uses
ctive charcoal as marker, however it was modiﬁed in 2004 by
arona and Lucchesi to improve the wellbeing of the animal, since
n this model the animals are not sacriﬁced and can be used again
n other experiments.
The results displayed in Table 3, show a signiﬁcant decrease
f the elimination time of the marker when it is compared to the
ontrol group.
ntestinal transit in metabolic cage
In this model were evaluated the EEtOH and the infusion
xtracts of O. macrocarpa. It is important to highlight that in this
odel, animals are placed in a metabolic cage and the activity
s determined by the weight of the faeces eliminated during the
bservation period, thus animals are not sacriﬁced and can be used
gain in other experiments.
Table 4 shows the results. It can be observed a signiﬁcant dif-
erence of the weight of the faeces between the treated groups and
he control group, indicating that the EEtOH and infusion extracts
f O. macrocarpa also have stimulant activity of the intestine transit
n this model.
able 5
uantity of phenolic acids determined in the extracts of Operculina macrocarpa.a
Substances 
EEtOH extract 
Caffeic acid, 2 4.7 ± 2.9 
Chlorogenic acid, 1 1.1 ± 5.1 
3,4′-Dehydrodicaffeic acid, 3 1.9 ± 2.9 
NI  1 1.2 ± 2.4 
NI  2 2.4 ± 1.2 
a Each value represents de mean ± standard deviation (%) for 3 independent experimenFig. 2. HPLC separation chromatogram, in analytic mode (210 nm)  of the infusion
extract of Operculina macrocarpa. 1. clorogenic acid; 2. caffeic acid; 3. 3,4′-
dehydrodicaffeic acid; 4 and 5. Not identiﬁed.
In order to relate the pharmacological activity observed
with the metabolites found in this plant was  performed the
chromatographic proﬁle by HPLC-UV-PAD from the EEtOH and
infusion extracts of O. macrocarpa. The UV data showed intense
bands in the spectral range between 190–220 and 260–280 nm
conﬁrming the presence of ﬁve phenolic acids in these extracts
(Saldanha et al., 2013) (Figs. 1 and 2). For each compound assign-
ment, we used the comparison of retention time of the sample
chromatogram with those of standards, additionally we comparing
the absorption spectra for peaks obtained with those of standards
analyzed under the same chromatographic conditions. It was  per-
formed by co-injection of the authentic patterns or the metabolites
isolated from this plant (Figs. 1 and 2). The compounds 4 and 5
observed in the chromatographic proﬁle of EEtOH and infusion
extracts were not identiﬁed, but could be quantiﬁed through the
same proﬁle displayed on the UV absorption spectra. According
to the quantiﬁcation of phenolic acids in the EEtOH extract there
was a greater caffeic acid concentration (4.7 mg/g), followed by the
Concentration (mg/g) ± standard deviation
EEtOH without resin Infusion extract
5.1 ± 4.1 2.4 ± 3.1
1.1 ± 9.8 0.4 ± 5.5
1.5 ± 1.7 0.4 ± 2.9
1.0 ± 4.2 0.3 ± 1.5
1.9 ± 4.7 0.3 ± 3.5
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,4′-dehydrodicaffeic acid (1 mg/g) and chlorogenic acid (1.1 mg/g)
Table 5). The EEtOH extract without the resin showed a higher
oncentration of caffeic acid (5.1 mg/g) and a lower concentration
f 3,4′-dehydrodicaffeic acid (1.5 mg/g). It was possible to observe
he same level of chlorogenic acid in both EEtOH extract as in EETOH
xtract without resin. The infusion has a signiﬁcant reduction in the
ontent of both quantiﬁed acids.
onclusions
The phytochemical analysis of the EEtOH extract of the roots
f O. macrocarpa guided to the isolation and identiﬁcation of the
affeic and protocatechuic acids and the new 3,4′-dehydrodicaffeic
cid.
The EEtOH and infusion extracts were subjected to HPLC-
V-PDA chemical proﬁling and 5 principal peaks (1–5) were
etected (Figs. 1 and 2). The caffeic and chlorogenic acids and 3,4′-
ehydrodicaffeic acid were quantiﬁed in O. macrocarpa extracts.
he caffeic acid was found to be the characteristic component of
heses extracts.
The results obtained with the three experimental models tested
howed the laxative activity with increasing the intestinal motility
f all extracts of O. macrocarpa. The caffeic, ferulic, chlorogenic acids
nd the 3,4′-dehydrodicaffeic acid evaluated showed the laxative
ction. This effect is directly related to the content of caffeic, chloro-
enic acids and the 3,4′-dehydrodicaffeic acid in the extract. The
orrelation between the phenolic acids structures and the intestinal
otility we can suggest that activity involve the skeleton with the
onjugated acid portion and/or the phenolic without necessarily
ith the orto-dihydroxi system. Our results conﬁrm the traditional
se of this specie a laxative.
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